Unlocking the full potential of life.
Unlocking the full potential of life
Over 35 Years of Excellence in Health and Innovation
For more than 35 years, OPALIA PHARMA, a subsidiary of the international RECORDATI Group, has been a pioneer in advancing healthcare and driving innovation across Tunisia, Africa, and the MENA region.
Every day, we are committed to ensuring equitable access to safe, high-quality medicines, addressing the evolving needs of patients while actively contributing to the improvement of public health.
Image: Dr. Alya El Hedda, General Manager and Founder of Opalia Recordati.
At Opalia Recordati, we are committed to improving the health and quality of life of patients by ensuring accessible, high-quality treatments that comply with the strictest international standards. With our expertise and dedication to innovation, we place ethics, integrity, and social and societal responsibility at the heart of our actions.
As a key player in the pharmaceutical sector, we foster a collaborative and dynamic environment where every talent can thrive and unleash its full potential.
We are committed to being socially and environmentally responsible throughout all our activities
Global Operations
Recordati is a global pharmaceutical company, listed on the Italian stock exchange, with more than 4,450 employees. We develop and market medicines to serve people with common diseases, as well as those living with some of the rarest diseases, in around 150 countries.